Biotechnology: Security, Trade, and Dual-Use Risks

The Hormuz Gambit: Why the Iran War Is the Only Trade That Matters Right Now

Trump asked Japan, Australia, and NATO to send warships to the Gulf. Every single one said no. The oil markets haven't priced what that means yet. A deep-dive intelligence briefing on the Strait of Hormuz, US-Iran escalation, alliance fractures, and what it all means for your portfolio.

The Poor Man's Atom Bomb: How AI Broke the Nation-State Monopoly on Weapons of Mass Destruction

AI can now generate forty thousand novel mass casualty compounds in under six hours. DNA synthesis has fallen 99% in cost. The Biological Weapons Convention has no enforcement mechanism. In this episode of The Briefing Room, we break down the structural collapse of CBRN barriers — the Carlson Curve, the MegaSyn study, agentic AI risk, state actor programmes (Russia, China, Iran, North Korea), the BWC enforcement gap, the attribution problem, mirror life as an emerging existential risk, and how sophisticated investors should position for this accelerating threat environment. 26 sources. Full written report at alphabriefing.com [https://alphabriefing.com]

The Orbital Economy: Why AI's Next Battleground Is 40,000 Feet Up

SpaceX just filed to put one million satellites in orbit. Not for broadband — for AI computing. The $690 billion infrastructure race is leaving Earth, and most investors haven't priced in what that means. In this episode of The Briefing Room, we break down the convergence of the AI infrastructure megacycle and the space economy — and what it means for your capital. We cover: SpaceX's FCC filing for one million orbital data center satellites and Starlink V3 specs, Amazon Kuiper, Amazon Leo, and Google's Suncatcher — the hyperscalers going orbital, why space solves AI's core data movement problem, the $690 billion hyperscaler capex buildout, capital rotation from VC moonshots to infrastructure finance, the SpaceX IPO wildcard, Kessler Syndrome: the tail risk nobody is pricing in, and concrete investment plays. 52 minutes of intelligence-grade analysis. Written report at AlphaBriefing.com. This is analysis, not advice. We may hold positions in assets discussed. Always do your own research.

Official Denial: AARO, Whistleblowers, and the War for UAP Transparency

This episode of The Briefing Room dissects the profound conflict defining the current conversation around Unidentified Anomalous Phenomena (UAP). The U.S. government officially recognizes UAPs as a potential national security threat, yet the Executive Branch and Congress are deeply divided on what the phenomena represent. We analyze the core claims alleging decades of government concealment: the Whistleblowers, the Secret USAP allegedly code-named IMMACULATE CONSTELLATION, and the Official Rebuttal from AARO. We also examine the scientific push for transparency from researchers like Harvard's Avi Loeb and Stanford's Dr. Garry Nolan. This podcast was created utilizing artificial intelligence deep research with over 187 sources and was reviewed by a human editor prior to publication.

Biotechnology: Security, Trade, and Dual-Use Risks

As biotechnology races ahead—fueled by synthetic biology, CRISPR, and global trade—so do the risks. In this AlphaBriefing episode, we break down the emerging security threats at the intersection of biology, geopolitics, and illicit networks. We unpack real-world cases of biological material smuggling, how wildlife and animal trafficking intersect with pandemic risk, and how dual-use technologies can be weaponized. From bioeconomy espionage to lapses in global oversight, this briefing analyzes why existing treaties like the Biological Weapons Convention are falling behind. Featuring insights from 13 key sources. Topics: Biosecurity, synthetic biology, illicit trade, dual-use risks, intelligence, governance.